Galena Biopharma (GALE) Announces Receipt of FDA Fast-Track Designation for NeuVax Combo in Breast Cancer
Tweet Send to a Friend
Galena Biopharma, Inc. (Nasdaq: GALE) announced the U.S. Food and Drug Administration (FDA) has designated NeuVax™ (nelipepimut-S), combined with recombinant ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
